SANJEEV JAIN MD NPI 1851497341

NPI Information

  • NPI: 1851497341
  • Provider Name: SANJEEV JAIN, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 285 SILLS RD BLDG 16
    EAST PATCHOGUE, NY
    ZIP 11772
  • Phone: (631) 751-3000

Map and Directions

Get Directions

NPI Details

Sanjeev Jain, MD is a hematology and oncology internal medicine in East Patchogue, NY. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sanjeev Jain, MD NPI is 1851497341. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

285 SILLS RD BLDG 16
EAST PATCHOGUE, NY
ZIP 11772-808
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1851497341 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Phosphate level (HCPCS:84100)
  • Magnesium level (HCPCS:83735)
  • Uric acid level, blood (HCPCS:84550)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Folic acid level, serum (HCPCS:82746)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Protein measurement, serum (HCPCS:84165)
  • Red blood count, manual test (HCPCS:85044)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Vitamin d-3 level (HCPCS:82306)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Blood test, clotting time (HCPCS:85610)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Acute hepatitis panel (HCPCS:80074)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Hemoglobin a1c level (HCPCS:83036)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Bilirubin level, total (HCPCS:82247)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Urinalysis, manual test (HCPCS:81002)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Gene analysis (calreticulin), common variants (HCPCS:81219)
  • Gene analysis (janus kinase 2) variant (HCPCS:81270)
  • Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
  • Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
  • Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Transitional care management services for problem of moderate complexity (HCPCS:99495)
  • Rheumatoid factor level (HCPCS:86431)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Ct guidance for insertion of radiation therapy fields (HCPCS:77014)

The enumeration date for this NPI number is 9/15/2006 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology225429NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.